C
Chris Murray
Physician and health economist; founder and director of the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, lead of the Global Burden of Disease study.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
Oct 5, 2026
Investing in health as a public good
7:17
7:40
8:08
R
7:11Rhonda StewartHOST
So what will they be able to see in the data in 2030, for example, that they can't see today?
Chris MurrayGUEST
So what we've learned along the way in the now 35 years of the Global Burden of Disease work is initially that started out at a regional level when it was done for the World Bank in 1991 to 93.
Chris MurrayGUEST
And then in the last 20 years, where it's been based at the Institute for Health Metrics and Evaluation, We have been able to, where certain countries have asked for it, we've been able to do the burden of disease analysis at the sub-national level.
Chris MurrayGUEST
Soon thereafter, Mexico and Brazil and India and China Nigeria were added, Norway, New Zealand, and Brazil.
R
9:52Rhonda StewartHOST
Can you think of a specific example where, because we were able to go deeper and to be more granular at the subnational level, there was something that was revealed that was especially useful to decision makers and maybe even help them to change or take a decision?